| 01.12.2021 19:04:02 | |
|---|---|
| Cena | |
| 140,90 EUR | |
| Změna | 2,12% (2,92) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Stuttgart |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 367.287 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - (0) |
| Prodej (částka) | - (0) |
| Otevírací cena | 138,14 EUR |
| Max | 140,90 EUR |
| Min | 138,14 EUR |
| Závěrečná cena (předchozí den) | 137,98 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 377 |
| Obchodovaný objem | 52.380,00 |
| Počet obchodů | 15 |
| Poslední zobchodovaný počet | 0 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 01.12.2021 |
|
Global Equity Ratings |
|
| 05.11.2021 |
|
Global Equity Ratings |
|
| 03.11.2021 |
|
Global Equity Ratings |
|
| 19.10.2021 |
|
Global Equity Ratings |
|
| 29.09.2021 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 01.12.2021 | 17:35 | 140,32 EUR | 1,01 | 250 |
| Vienna Stock Exchange | 01.12.2021 | 17:32 | 140,30 EUR | 0,04 | 10 |
| Tradegate | 01.12.2021 | 22:26 | 139,78 EUR | 1,95 | 248 |
| Stuttgart | 01.12.2021 | 19:04 | 140,90 EUR | 0,05 | 15 |
| SIX Swiss Exchange | 15.11.2019 | 17:35 | 145,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 01.12.2021 | 22:10 | 158,08 USD | 1.557,58 | 119.232 |
| Munich | 01.12.2021 | 17:58 | 140,78 EUR | 0,01 | 4 |
| London Stock Exchange | 01.12.2021 | 17:35 | 159,50 USD | 0,07 | 26 |
| Hanover | 01.12.2021 | 08:05 | 138,32 EUR | 0,00 | 1 |
| Hamburg | 01.12.2021 | 13:32 | 138,60 EUR | 0,02 | 4 |
| Frankfurt | 01.12.2021 | 20:50 | 141,02 EUR | 0,13 | 21 |
| Duesseldorf | 01.12.2021 | 19:31 | 140,84 EUR | 0,00 | 10 |
| Berlin | 01.12.2021 | 08:08 | 138,14 EUR | 0,00 | 1 |
| 01.12.2021 19:04:02 | |
|---|---|
| Cena | |
| 140,90 EUR | |
| Změna | 2,12% (2,92) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Stuttgart |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 367.287 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - (0) |
| Prodej (částka) | - (0) |
| Otevírací cena | 138,14 EUR |
| Max | 140,90 EUR |
| Min | 138,14 EUR |
| Závěrečná cena (předchozí den) | 137,98 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 377 |
| Obchodovaný objem | 52.380,00 |
| Počet obchodů | 15 |
| Poslední zobchodovaný počet | 0 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +3,88% | +15,15% | +9,56% |
| Výkonn. (abs.) | +5,26 | +18,54 | +12,29 |
| Beta | 0,51 | 0,46 | 0,64 |
| Volatilita | 14,68 | 15,61 | 23,25 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 140,64 EUR (1.203) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 141,77 EUR (968) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 143,20 EUR (703) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 138,43 EUR (1.438) |
| YTD Max| datum | 153,64 EUR (20.08.2021) |
| YTD Min | datum | 126,08 EUR (04.01.2021) |
| 52týdenní max. | datum | 153,64 EUR (20.08.2021) |
| 52týdenní min. | datum | 121,70 EUR (03.12.2020) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| Charles Prince | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Jim Wennerlid | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Ronald Williams | Member of Board of Directors |
| Alex Gorsky (bis 3.01.2022) | Chairman of Managing Board |
| Peter M. Fasolo | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joaquin Duato (CEO ab 3.01.2022) | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Michael Sneed | Member of Executive Committee |
| Paulus Stoffels, M.D. (bis 31.12.2021) | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |